Inhibition of Cell Migration by PITENINs: The Role of ARF6

DSpace/Manakin Repository

Inhibition of Cell Migration by PITENINs: The Role of ARF6

Citable link to this page

 

 
Title: Inhibition of Cell Migration by PITENINs: The Role of ARF6
Author: Skidan, Igor; Yang, Jinsheng; Fu, Xueyan; Famulok, Michael; Schaffhausen, Brian; Torchilin, Vladimir; Degterev, Alexei; Miao, Benchun; You, Zerong; Yuan, Junying

Note: Order does not necessarily reflect citation order of authors.

Citation: Miao, Benchun, Igor Skidan, Jinsheng Yang, Zerong You, Xueyan Fu, Michael Famulok, Brian Schaffhausen, Vladimir Torchilin, Junying Yuan, and Alexei Degterev. 2012. Inhibition of cell migration by PITENINs: The role of ARF6. Oncogene 31(39): 4317-4332.
Full Text & Related Files:
Abstract: We have previously reported the development of small molecule phosphatidylinositol-3,4,5-trisphosphate (PIP3) antagonists (PITs) that block pleckstrin homology (PH) domain interaction, including activation of Akt, and show anti-tumor potential. Here we show that the same molecules inhibit growth factor-induced actin remodeling, lamellipodia formation and, ultimately, cell migration and invasion, consistent with an important role of PIP3 in these processes. In vivo, a PIT-1 analog displays significant inhibition on tumor angiogenesis and metastasis. ADP ribosylation factor 6 (ARF6) was recently identified as an important mediator of cytoskeleton and cell motility, which is regulated by PIP3-dependent membrane translocation of the guanine nucleotide exchange factors (GEFs) such as ADP-ribosylation factor nucleotide binding-site opener (ARNO) and general receptor for 3-phosphoinositides (GRP1). We demonstrate that PITs inhibit PIP3/ARNO or GRP1 PH domain binding and membrane localization, resulting in the inhibition of ARF6 activation. Importantly, we show that expression of the constitutively active mutant of Arf6 attenuates inhibition of lamellipodia formation and cell migration by PITs, confirming that inhibition of Arf6 contributes to inhibition of these processes by PITs. Overall, our studies demonstrate the feasibility of developing specific small molecule targeting PIP3 binding by PH domains as potential anti-cancer agents that can simultaneously interfere with cancer development at multiple points.
Published Version: doi:10.1038/onc.2011.593
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310973/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:10623006
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters